Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Rad Laboratories
Hercules, California, USAbio-rad.com ↗
- Ownership
- Public · BIO
- Employees
- ~8000
- Development stage
- Commercial
01
Overview
Bio-Rad’s products are widely adopted in both research and clinical settings. Their diagnostic assays are FDA-cleared/CE-marked where required. The company does not conduct clinical trials for therapeutics but has a strong record of commercial product launches in diagnostics and life science tools.
- Therapeutic areas
- HematologyEndocrinologyImmunologyInfectious Diseases
- Modalities
- Antibodies (monoclonal and polyclonal)Reagents for molecular biology (PCR, qPCR, ddPCR)Chromatography media/resinsFlow cytometry reagents
- Industry
- Molecular Diagnostics
02
Partnerships
Collaborates with academic institutionsSupplies to pharmaceutical companies globally
03
Financials
- Market cap
- $9.9B
- Total revenue
- $2.6B
- Enterprise value
- $9.6B
Beyond the preview
Go deeper on Bio-Rad Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-Rad Laboratories.